These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

170 related articles for article (PubMed ID: 30773235)

  • 1. Corrigendum to "Cerebral dopamine neurotrophic factor protects microglia by combining with AKT and by regulating FoxO1/mTOR signaling during neuroinflammation" [Biomed. Pharmacother. 109 (2018) 2278-2284].
    Zhang Y; Xiang Y; Wang X; Zhu L; Li H; Wang S; Pan X; Zhao H
    Biomed Pharmacother; 2019 Apr; 112():108548. PubMed ID: 30773235
    [No Abstract]   [Full Text] [Related]  

  • 2. Corrigendum to "ZSCAN16 promotes proliferation, migration and invasion of bladder cancer via regulating NF-kB, AKT, mTOR, P38 and other genes" [Biomed. Pharmacother. 126 (2020) 110066].
    Li X; Shang D; Shen H; Song J; Hao G; Tian Y
    Biomed Pharmacother; 2020 Oct; 130():110858. PubMed ID: 33054976
    [No Abstract]   [Full Text] [Related]  

  • 3. Corrigendum to "Huachansu capsule inhibits the proliferation of human gastric cancer cells via Akt/mTOR pathway" [Biomed. Pharmacother. 118 (2019) 109241].
    Ni T; Wang H; Li D; Tao L; Lv M; Jin F; Wang W; Feng J; Qian Y; Sunagawa M; Liu Y
    Biomed Pharmacother; 2020 Mar; 123():109823. PubMed ID: 31959384
    [No Abstract]   [Full Text] [Related]  

  • 4. Corrigendum to "MiR-25-3p promotes malignant phenotypes of retinoblastoma by regulating PTEN/Akt pathway" [Biomed. Pharmacother. 118 (2019) 109111].
    Wan W; Wan W; Long Y; Li Q; Jin X; Wan G; Zhang F; Lv Y; Zheng G; Li Z; Zhu Y
    Biomed Pharmacother; 2020 Nov; 131():110842. PubMed ID: 33092949
    [No Abstract]   [Full Text] [Related]  

  • 5. Corrigendum to "Dexmedetomidine protects H9C2 against hypoxia/reoxygenation injury through miR-208b-3p/Med13/Wnt signaling pathway axis" [Biomed. Pharmacother. 125 (2020) 110001].
    Wang Z; Yang Y; Xiong W; Zhou R; Song N; Liu L; Qian J
    Biomed Pharmacother; 2020 Oct; 130():110841. PubMed ID: 33032881
    [No Abstract]   [Full Text] [Related]  

  • 6. Corrigendum to "Ischemic postconditioning exerts neuroprotective effect through negatively regulating PI3K/Akt2 signaling pathway by microRNA-124" [Biomed. Pharmacother. 126 (2020) 109786].
    Miao W; Yan Y; Bao TH; Jia WJ; Yang F; Wang Y; Zhu YH; Yin M; Han JH
    Biomed Pharmacother; 2020 Sep; 129():110597. PubMed ID: 32798084
    [No Abstract]   [Full Text] [Related]  

  • 7. Corrigendum to "Baohuoside-1 targeting mTOR inducing apoptsis to inhibit hepatocellular carcinoma proliferation, invasion and migration" [Biomed. Pharmacother. 128 (2020) 110366].
    Guo Y; Zhu H; Weng M; Chen B; Wang C; Sun L
    Biomed Pharmacother; 2020 Sep; 129():110394. PubMed ID: 32561180
    [No Abstract]   [Full Text] [Related]  

  • 8. Corrigendum to "Baohuoside-1 targeting mTOR inducing apoptsis to inhibit hepatocellular carcinoma proliferation, invasion and migration" [Biomed. Pharmacother. 2020 (128) 110366].
    Guo Y; Zhu H; Weng M; Chen B; Wang C; Sun L
    Biomed Pharmacother; 2020 Oct; 130():110631. PubMed ID: 32828598
    [No Abstract]   [Full Text] [Related]  

  • 9. Corrigendum to "Anti-hypertrophy effect of atorvastatin on myocardium depends on AMPK activation-induced miR-143-3p suppression via Foxo1" [Biomed. Pharmacother. 106 (2018) 1390-1395].
    Yu B; Liu D; Zhang H; Xie D; Nie W; Shi K; Yang P
    Biomed Pharmacother; 2024 Feb; 171():116141. PubMed ID: 38218631
    [No Abstract]   [Full Text] [Related]  

  • 10. Corrigendum to "Saikosaponin A inhibits the activation of pancreatic stellate cells by suppressing autophagy and the NLRP3 inflammasome via the AMPK/mTOR pathway" [Biomed. Pharmacother. 128 (2020) 110216].
    Cui L; Li C; Zhuo Y; Yang L; Cui N; Li Y; Zhang S
    Biomed Pharmacother; 2020 Oct; 130():110685. PubMed ID: 32893050
    [No Abstract]   [Full Text] [Related]  

  • 11. Corrigendum to "Apoptosis induction and AKT/NF-κB inactivation are associated with regroafenib-inhibited tumor progression in non-small cell lung cancer in vitro and in vivo" [Biomed. Pharmacother. 116 (2019) 109032].
    Weng MC; Li MH; Chung JG; Liu YC; Jeng-Yuan W; Hsu FT; Wang HE
    Biomed Pharmacother; 2019 Oct; 118():109209. PubMed ID: 31324388
    [No Abstract]   [Full Text] [Related]  

  • 12. 'Corrigendum to "Resveratrol inhibits proliferation, migration and invasion via Akt and ERK1/2 signaling pathways in renal carcinoma cells" [Biomed. Pharmacother. 98 (2018) 36-44]'.
    Zhao Y; Tang H; Zeng X; Ye D; Liu J
    Biomed Pharmacother; 2022 Sep; 153():113329. PubMed ID: 35760645
    [No Abstract]   [Full Text] [Related]  

  • 13. Corrigendum to "17β-Estradiol/extrogen receptor β alleviates apoptosis and enhances matrix biosynthesis of nucleus pulposus cells through regulating oxidative damage under a high glucose condition" [Biomed. Pharmacother. 207 (2018) 1004-1009].
    Yang D; Zhu D; Zhu S; Feng F; Gong C; Chen C; Chen L
    Biomed Pharmacother; 2019 Apr; 112():108739. PubMed ID: 30852062
    [No Abstract]   [Full Text] [Related]  

  • 14. Corrigendum to "Schisandrin A inhibits triple negative breast cancer cells by regulating Wnt/ER stress signaling pathway" [Biomed. Pharmacother. 115 (2019) 108922].
    Xu X; Rajamanicham V; Xu S; Liu Z; Yan T; Liang G; Guo G; Zhou H; Wang Y
    Biomed Pharmacother; 2022 May; 149():112865. PubMed ID: 35367116
    [No Abstract]   [Full Text] [Related]  

  • 15. Corrigendum to "Linc00152 promotes tumorigenesis by regulating DNMTs in triple-negative breast cancer" [Biomed Pharmacother. 97 (2018) 1275-1281].
    Wu J; Shuang Z; Zhao J; Tang H; Liu P; Zhang L; Xie X; Xiao X
    Biomed Pharmacother; 2020 Jul; 127():110174. PubMed ID: 32423656
    [No Abstract]   [Full Text] [Related]  

  • 16. Corrigendum to "Incretin hormones receptor signaling plays the key role in antidiabetic potential of PTY-2 against STZ-induced pancreatitis" [Biomed. Pharmacother. 97 (330-338) 330-338].
    Srivastava S; Shree P; Pandey H; Tripathi YB
    Biomed Pharmacother; 2018 Nov; 107():1795. PubMed ID: 30115498
    [No Abstract]   [Full Text] [Related]  

  • 17. Corrigendum to 'Metapristone suppresses non-small cell lung cancer proliferation and metastasis via modulating RAS/RAF/MEK/MAPK signaling pathway' [Biomed. Pharmacother. 90 (2017) 437-445].
    Zheng G; Shen Z; Chen H; Liu J; Jiang K; Fan L; Jia L; Shao J
    Biomed Pharmacother; 2018 Feb; 98():925-926. PubMed ID: 29421862
    [No Abstract]   [Full Text] [Related]  

  • 18. Corrigendum to "Amiodarone induces cell proliferation and myofibroblast differentiation via ERK1/2 and p38 MAPK signaling in fibroblasts" [Biomed. Pharmacother. 115 (2019) 108889].
    Weng J; Tu M; Wang P; Zhou X; Wang C; Wan X; Zhou Z; Wang L; Zheng X; Li J; Chen C; Wang Z; Wang Z
    Biomed Pharmacother; 2019 Oct; 118():109085. PubMed ID: 31178264
    [No Abstract]   [Full Text] [Related]  

  • 19. Corrigendum to "Exosomes: An emerging factor in atherosclerosis" [Biomed. Pharmacother. 115 (2019) 108951].
    Wang Y; Xie Y; Zhang A; Wang M; Fang Z; Zhang J
    Biomed Pharmacother; 2019 Oct; 118():109119. PubMed ID: 31230947
    [No Abstract]   [Full Text] [Related]  

  • 20. Corrigendum to: 'Protective effect of vaginal resveratrol administration on joint tissues in ovariectomized rats: Targeting mTOR and сaspase 3' [Biomed. Pharmacother. (2023) 115176/165].
    Zaychenko G; Belenichev I; Hnatiuk V; Doroshenko A; Sinitsyna O; Sulaieva O; Falalyeyeva T; Kobyliak N
    Biomed Pharmacother; 2024 Jun; ():117020. PubMed ID: 38937200
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.